Evidence map›Paper›PMID 26185390›Full record

ArticleWorld journal of gastroenterology2015

Management of hepatocellular carcinoma rupture in the caudate lobe.

De-Fei Hong, Ying-Bin Liu, Shu-You Peng, Jin-Zhong Pang, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Transarterial chemoembolizationOncology research · 2022
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

De-Fei HongDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Ying-Bin LiuDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Shu-You PengDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Jin-Zhong PangDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Zhi-Fei WangDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Jian ChengDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Guo-Liang ShenDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Yuan-Biao ZhangDe-Fei Hong, Shu-You Peng, Zhi-Fei Wang, Jian Cheng, Guo-Liang Shen, Yuan-Biao Zhang, Department of Hepatobiliary, Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang Province, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo demonstrate that caudate lobectomy is a valid treatment in cases of hepatocellular carcinoma (HCC) rupture in the caudate lobe based on our experience with the largest case series reported to date.

methodsA retrospective study of eight patients presenting with spontaneous rupture and hemorrhage of HCC in the caudate lobe was conducted. Two patients underwent ineffective transarterial embolization preoperatively. Caudate lobectomy was performed in all eight patients. Bilateral approach was taken in seven cases for isolated complete caudate lobectomy. Left-sided approach was employed in one case for isolated partial caudate lobectomy. Transarterial chemoembolization was performed postoperatively in all patients.

resultsCaudate lobectomy was successfully completed in all eight cases. The median time delay from the diagnosis to operation was 5 d (range: 0.25-9). Median operating time was 200 min (range: 120-310) with a median blood loss of 900 mL (range: 300-1500). Five patient remained in long-term follow-up, with one patient becoming lost to follow-up at 3 years and two patients currently alive at 7 and 19 mo. One patient required reoperation due to recurrence. Gamma knife intervention was performed for brain metastasis in another case. Two patients survived for 10 and 84 mo postoperatively, ultimately succumbing to multiple organ metastases.

conclusionCaudate lobectomy is the salvage choice for HCC rupture in the caudate lobe. Local anatomy and physiologic features of the disease render caudate lobectomy a technically difficult operation. Postponement of surgical intervention is thus recommended while the rupture remains hemodynamically stable until an experienced surgeon becomes available. Prognosis is confounded by numerous factors, but long-term survival can be expected in the majority of cases.

Indexed as

AdultBlood Loss, SurgicalCarcinoma, HepatocellularChemoembolization, TherapeuticChemotherapy, AdjuvantDisease ProgressionEmbolization, TherapeuticHepatectomyHumansLiver NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalOperative TimeReoperationRetrospective StudiesCaudate lobectomyEmergencyHepatocellular carcinomaRuptureTransarterial embolization

Identifiers

PMID26185390
PMCPMC4499361
OpenAlexW2400999718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.